Aernoud Fiolet

71 Viewing Atherosclerosis through a Crystal Lens 73. I. Nadra, J.C. Mason, P. Philippidis, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways. Circ Res, 96 (2005), pp. 1248-1256 74. P.A. McCullough, V. Agrawal, E. Danielewicz, G.S. Abela. Accelerated atherosclerotic calcification and Monckeberg’s sclerosis a continuum of advanced vascular pathology in chronic kid. Clin J Am Soc Nephrol, 3 (2008), pp. 1585-1595 75. S.M. Nidorf, P.L. Thompson. Why Colchicine Should Be Considered for secondary prevention of atherosclerosis: An overview. Clin Ther (2018), pp. 41-48 76. S.M. Nidorf, J.W. Eikelboom, C.A. Budgeon, P.L. Thompson. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol, 61 (2013), pp. 404-410 77. J.C. Tardif, S. Kouz, D.E. Waters, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med, 381 (2019), pp. 2497-2505 78. G.S. Abela, A. Vedre, A. Janoudi, R. Huang, S. Durga, U. Tamhane. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol, 107 (2011), pp. 1710-1717 79. C.Y.M. Adams, Y.H. Abdullah. The action of human high density lipoprotein on cholesterol crystals. Part 1. Light microscopic observations. Atherosclerosis, 31 (1978), pp. 465-471 80. H. Li, M.H. El-Dakdouki, D.C. Zhu, G.S. Abela, X. Huang. Synthesis of β -cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals. Chem Commun, 48 (2012), pp. 3385-3387 81. S.M. Liu, A. Cogny, M. Kockx, et al. Cyclodextrins differentially mobilize free and esterified cholesterol from primary human foam cell macrophages. J Lipid Res, 44 (2003), pp. 1156-1166 82. S. Zimmer, A. Grebe, S.S. Bakke, et al. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci Transl Med, 8 (333) (2016), p. 333ra50